Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geneviève McCluskey

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Immunobiology|August 26, 2023
Complement and coagulation crosstalk - Factor H in the spotlightMeike Heurich, Geneviève McCluskey
Hemasphere|May 8, 2026
Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoformsGeneviève McCluskey, Hortense Maynadié, Delphine Borgel, et al.
Haematologica|March 13, 2025
Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptidesAlejandra Reyes-Ruiz, Sandrine Delignat, Aurélien Azam, et al.
Blood|April 15, 2024
Fitusiran reduces bleeding in factor X-deficient miceSebastien Verhenne, Geneviève McCluskey, Hortense Maynadié, et al.
Haematologica|April 3, 2025
Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic miceThibaud Sefiane, Geneviève McCluskey, Marie Clavel, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2023
MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylationAlexandre Kauskot, Coralie Mallebranche, Arnaud Bruneel, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Immunobiology|August 26, 2023
Complement and coagulation crosstalk - Factor H in the spotlightMeike Heurich, Geneviève McCluskey
Hemasphere|May 8, 2026
Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoformsGeneviève McCluskey, Hortense Maynadié, Delphine Borgel, et al.
Haematologica|March 13, 2025
Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptidesAlejandra Reyes-Ruiz, Sandrine Delignat, Aurélien Azam, et al.
Blood|April 15, 2024
Fitusiran reduces bleeding in factor X-deficient miceSebastien Verhenne, Geneviève McCluskey, Hortense Maynadié, et al.
Haematologica|April 3, 2025
Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic miceThibaud Sefiane, Geneviève McCluskey, Marie Clavel, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2023
MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylationAlexandre Kauskot, Coralie Mallebranche, Arnaud Bruneel, et al.
Pageof 1